PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.
Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...
Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral ...
HealthDay News — Some canned tuna associated with a 2025 recall has been pulled from grocery stores in 9 states, federal ...
No evidence of association for CWF with birth weight or other birth outcomes in study of >11 million singleton births.
Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.
New research on acetaminophen use during pregnancy; the chikungunya vaccine Ixchiq is withdrawn; FDA approves Nexplanon for up to 5 years of use; suicidal ideation warning removed from GLP-1s; at-home ...
More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback